Glanbia faces potential legal action from Japanese firm

Chemical manufacturer Kaneka alleges that the Irish food-ingredients giant has infringed on two of its patents relating to nutritional supplements

8th March, 2020
Glanbia faces potential legal action from Japanese firm
Kaneka has accused Glanbia and Anthem of infringing its patents by importing and selling a supplement known as ubiquinol acetate

Glanbia is facing potential legal action in the United States after a Japanese firm filed a lawsuit alleging that the Irish food-ingredients giant and its supplier had infringed on two of its patents.

Kaneka Corporation, an Osaka-based chemical manufacturing company, last month filed an action for patent infringement in Delaware against Glanbia Nutritionals and Indian firm Anthem Biosciences.

Kaneka has accused Glanbia and Anthem of infringing its patents by importing and selling a supplement known...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Irish funds industry hits record high of $4.2 trillion, new data shows

Markets Barry J Whyte 17 hours ago

How I work: ‘Take risks and back yourself, you don’t have to tick every box to put your hand up’

How to manage: Human experience will be central to recruiting new talent post-pandemic

Movers and Shakers: Three senior appointments at Bank of Ireland